Total Payments
$5,374
2024 Payments
$2,765
Companies
26
Transactions
228
Medicare Patients
1,384
Medicare Billing
$148,636
Payment Breakdown by Category
Food & Beverage$5,223 (97.2%)
Education$150.64 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,223 | 225 | 97.2% |
| Education | $150.64 | 3 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,397 | 59 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,238 | 57 | $0 (2024) |
| Insmed, Inc. | $521.44 | 28 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $253.03 | 6 | $0 (2024) |
| GENZYME CORPORATION | $243.58 | 10 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $229.24 | 7 | $0 (2024) |
| United Therapeutics Corporation | $191.80 | 5 | $0 (2024) |
| ABBVIE INC. | $134.79 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $129.16 | 7 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $114.95 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,765 | 125 | AstraZeneca Pharmaceuticals LP ($646.91) |
| 2023 | $2,105 | 86 | GlaxoSmithKline, LLC. ($743.10) |
| 2022 | $503.12 | 17 | Mallinckrodt Hospital Products Inc. ($150.00) |
All Payment Transactions
228 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.74 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.30 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $40.85 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.86 | General |
| Category: Immunology | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Education | In-kind items and services | $11.66 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Cardiology | ||||||
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.03 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,119 | 1,942 | $323,749 | $122,705 |
| 2022 | 9 | 265 | 449 | $71,010 | $25,931 |
Total Patients
1,384
Total Services
2,391
Medicare Billing
$148,636
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 223 | 670 | $93,800 | $40,035 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 220 | $49,500 | $19,894 | 40.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 37 | 156 | $31,044 | $14,135 | 45.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 101 | 101 | $33,330 | $11,153 | 33.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 66 | 75 | $24,750 | $9,800 | 39.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 69 | 70 | $17,500 | $6,724 | 38.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 137 | 172 | $25,800 | $6,709 | 26.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 83 | 157 | $15,700 | $5,955 | 37.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 139 | 177 | $16,815 | $3,335 | 19.8% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 44 | 48 | $7,200 | $2,871 | 39.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 69 | 78 | $7,410 | $1,879 | 25.4% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 16 | 18 | $900.00 | $215.64 | 24.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 74 | 231 | $32,340 | $12,360 | 38.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $9,240 | $3,389 | 36.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 25 | 26 | $6,500 | $2,650 | 40.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 14 | $4,620 | $2,093 | 45.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 35 | 59 | $5,900 | $1,725 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 15 | $3,375 | $1,437 | 42.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 33 | 33 | $4,950 | $1,381 | 27.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 31 | 31 | $2,945 | $601.09 | 20.4% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 12 | 12 | $1,140 | $294.72 | 25.9% |
About Dr. Brent Bermingham, MD
Dr. Brent Bermingham, MD is a Critical Care Medicine healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2016. The National Provider Identifier (NPI) number assigned to this provider is 1144674227.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brent Bermingham, MD has received a total of $5,374 in payments from pharmaceutical and medical device companies, with $2,765 received in 2024. These payments were reported across 228 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($5,223).
As a Medicare-enrolled provider, Bermingham has provided services to 1,384 Medicare beneficiaries, totaling 2,391 services with total Medicare billing of $148,636. Data is available for 2 years (2022–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease, Pulmonary Disease
- Location Augusta, GA
- Active Since 04/14/2016
- Last Updated 08/11/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1144674227
Products in Payments
- DUPIXENT (Biological) $531.81
- FASENRA (Biological) $530.34
- Arikayce (Drug) $521.44
- TEZSPIRE (Biological) $398.73
- AREXVY (Drug) $363.10
- NUCALA (Biological) $349.83
- TRELEGY ELLIPTA (Drug) $338.40
- ACTHAR (Biological) $253.03
- TYVASO (Drug) $191.80
- BREZTRI (Drug) $168.18
- AIRSUPRA (Drug) $153.72
- GLASSIA (Biological) $114.95
- Da Vinci Surgical System (Device) $104.42
- OFEV (Drug) $100.00
- UPTRAVI (Drug) $97.23
- Fetroja (Drug) $84.60
- AVYCAZ (Drug) $80.30
- Adempas (Drug) $59.79
- TEFLARO (Drug) $54.49
- Rezzayo (Drug) $46.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Augusta
Bruce Friedman, M.d, M.D
Critical Care Medicine — Payments: $1.0M
Critical Care Medicine $1.0M
Dr. Carmel Joseph, Md, MD
Critical Care Medicine — Payments: $44,125
Critical Care Medicine $44,125
Shaheen Islam, Mbbs, MBBS
Critical Care Medicine — Payments: $21,874
Critical Care Medicine $21,874
Dr. Varsha Kulkarni, M.d, M.D
Critical Care Medicine — Payments: $14,293
Critical Care Medicine $14,293
Dr. Scott Pethke, M.d, M.D
Critical Care Medicine — Payments: $14,046
Critical Care Medicine $14,046
Dr. Anthony Ramage, Do, DO
Critical Care Medicine — Payments: $2,621
Critical Care Medicine $2,621